Australia markets closed

Genovate Biotechnology Co., Ltd. (4130.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
24.40+0.05 (+0.21%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
536,296
528,512
438,759
434,254
472,723
Cost of revenue
320,799
317,596
283,889
284,500
279,617
Gross profit
215,497
210,916
154,870
149,754
193,106
Operating expenses
Research development
72,365
73,613
61,878
55,427
54,933
Selling general and administrative
111,131
110,310
106,885
95,490
98,706
Total operating expenses
183,496
183,923
168,763
150,917
153,639
Operating income or loss
32,001
26,993
-13,893
-1,163
39,467
Interest expense
196
267
281
252
253
Income before tax
36,898
30,825
-9,001
3,568
40,756
Income tax expense
3,982
1,491
3,322
3,196
2,025
Income from continuing operations
32,916
29,334
-12,323
372
38,731
Net income
32,916
29,334
-12,323
372
38,731
Net income available to common shareholders
32,916
29,334
-12,323
372
38,731
Basic EPS
0.28
0.27
-0.11
0.00
0.36
Diluted EPS
0.28
0.27
-0.11
0.00
0.36
Basic average shares
127,343
109,376
107,892
107,876
107,876
Diluted average shares
127,343
109,508
107,892
107,926
108,072